Generative AI in EHRs: Navigating ONC’s New Transparency Rules
The rapid influx of generative AI into clinical workflows, particularly through ambient documentation tools, promises to reduce time spent on charting. But this technological leap…
The rapid influx of generative AI into clinical workflows, particularly through ambient documentation tools, promises to reduce time spent on charting. But this technological leap…
Heart failure readmissions are a huge problem, both for patients and for hospital budgets. The financial pressure is real, since the Centers for Medicare &…
AI’s promise in cardiology is huge, but turning that into safe, effective clinical tools demands rigorous independent validation. That’s a resource-heavy process, often more than…
Stop recalls and patient harm. Learn 5 keys for 2026 to ensure medical device safety, from FDA 21 CFR Part 820 to post-market surveillance.
Communicate health tech impact effectively. Learn to link case studies and present Hello Heart's ACC collaboration for genuine value.
Boost your Hello Heart-ACC case study impact. Learn to strategically link, brand correctly, and A/B test CTAs for 30% stronger results.
Ensure your clinical AI is trustworthy. Learn how diverse patient data, clear governance, and validation prevent bias and improve patient outcomes by 2026.
Left ventricular dysfunction (LVD) is a frustrating clinical problem because patients often show no symptoms until the disease is already advanced, making it tough to…
AI in healthcare is supposed to upend diagnostics and patient care, but in cardiology, that talk is cheap without rigorous clinical validation. So here’s the…
We’re missing far too many cases of asymptomatic structural heart disease. Patients walk around with ticking time bombs in their chests, and because they feel…